Sfoglia per AUTORE
BERTOLOTTO A
Collezione AOU San Luigi di Orbassano

  

Items : 130

Long-term effectiveness of natalizumab in secondary progressive multiple sclerosis: A propensity-matched study. in Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics / Neurotherapeutics. 2024 Jul;21(4):e00363. doi: 10.1016/j.neurot.2024.e00363. Epub 2024 May 7.
2024
AOU San Luigi di Orbassano

Chisari CG; Aguglia U; Amato MP; Bergamaschi R; Bertolotto A; Bonavita S; Morra VB; Cavalla P; Cocco E; Conte A; Cottone S; De Luca G; Di Sapio A; Filippi M; Gallo A; Gasperini C; Granella F; Lus G; Maimone D; Maniscalco GT; Marfia G; Moiola L; Paolicelli D; Pesci I; Ragonese P; Rovaris M; Salemi G; Solaro C; Totaro R; et alii...

2024
AOU San Luigi di Orbassano

Malucchi S; Bava CI; Valentino P; Martire S; Lo Re M; Bertolotto A; Di Sapio A;

Prevalence of elevated sNFL in a real-world setting: Results on 908 patients with different multiple sclerosis types and treatment conditions. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2024 Aug;88:105748. doi: 10.1016/j.msard.2024.105748. Epub 2024 Jun 29.
2024
AOU San Luigi di Orbassano

Bava CI; Valentino P; Malucchi S; Bottero R; Martire S; Sapio AD; Bertolotto A;

Serum Neurofilaments are a reliable biomarker to early detect PML in Multiple Sclerosis patients. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2023 Sep;77:104893. doi: 10.1016/j.msard.2023.104893. Epub 2023 Jul 16.
2023
AOU San Luigi di Orbassano

Valentino P; Malucchi S; Bava CI; Martire S; Capobianco M; Malentacchi M; Sperli F; Oggero A; Di Sapio A; Bertolotto A;

Applying multidimensional computerized adaptive testing to the MSQOL-54: a simulation study. in Health and quality of life outcomes / Health Qual Life Outcomes. 2023 Jun 25;21(1):61. doi: 10.1186/s12955-023-02152-8.
2023
AOU San Luigi di Orbassano

Giordano A; Testa S; Bassi M; Cilia S; Bertolotto A; Quartuccio ME; Pietrolongo E; Falautano M; Grobberio M; Niccolai C; Allegri B; Viterbo RG; Confalonieri P; Giovannetti AM; Cocco E; Grasso MG; Lugaresi A; Ferriani E; Nocentini U; Zaffaroni M; De Livera A; Jelinek G; Solari A; Rosato R;

Cerebrospinal fluid neurofilament light chains predicts early disease-activity in Multiple Sclerosis. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2023 Dec;80:105131. doi: 10.1016/j.msard.2023.105131. Epub 2023 Nov 7.
2023
AOU San Luigi di Orbassano

Toscano S; Oteri V; Chisari CG; Finocchiaro C; Lo Fermo S; Valentino P; Bertolotto A; Zappia M; Patti F;

2023
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Capobianco MA; Pautasso M; Bertolotto A; Valentino P; Martire S; Sala A; Sperli F; Malentacchi M; Malucchi S; Bruschi N;

Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis. in Journal of neurology, neurosurgery, and psychiatry / J Neurol Neurosurg Psychiatry. 2022 Sep 30:jnnp-2022-329657. doi: 10.1136/jnnp-2022-329657.
2022
AOU San Luigi di Orbassano

Landi D; Bovis F; Grimaldi A; Annovazzi PO; Bertolotto A; Bianchi A; Borriello G; Brescia Morra V; Bucello S; Buscarinu MC; Caleri F; Capobianco M; Capra R; Cellerino M; Centonze D; Cerqua R; Chisari CG; Clerico M; Cocco E; Cola G; Cordioli C; Curti E; d'Ambrosio A; D'Amico E; De Luca G; Di Filippo M; Di Lemme S; Fantozzi R; Ferraro D; et alii...

NURR1-deficient mice have age- and sex-specific behavioral phenotypes. in Journal of neuroscience research / J Neurosci Res. 2022 Sep;100(9):1747-1754. doi: 10.1002/jnr.25067. Epub 2022 May 20.
2022
AOU San Luigi di Orbassano

Montarolo F; Martire S; Chiara F; Allegra S; De Francia S; Hoxha E; Tempia F; Capobianco MA; Bertolotto A;

sNFL applicability as additional monitoring tool in natalizumab extended interval dosing regimen for RRMS patients. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2022 Nov;67:104176. doi: 10.1016/j.msard.2022.104176. Epub 2022 Sep 14.
2022
AOU San Luigi di Orbassano

Valentino P; Malucchi S; Martire S; Bava CI; Capobianco MA; Bertolotto A;

The Selective Agonist for Sphingosine-1-Phosphate Receptors Siponimod Increases the Expression Level of NR4A Genes in Microglia Cell Line. in Current issues in molecular biology / Curr Issues Mol Biol. 2022 Mar 7;44(3):1247-1256. doi: 10.3390/cimb44030083.
2022
AOU San Luigi di Orbassano

Montarolo F; Martire S; Marnetto F; Valentino P; Valverde S; Capobianco MA; Bertolotto A;

The impact of pre-freezing storage time and temperature on gene expression of blood collected in EDTA tubes. in Molecular biology reports / Mol Biol Rep. 2022 Jun;49(6):4709-4718. doi: 10.1007/s11033-022-07320-5. Epub 2022 Mar 12.
2022
AOU San Luigi di Orbassano

Martire S; Valentino P; Marnetto F; Mirabile L; Capobianco M; Bertolotto A;

2022
ASL Cuneo 1
AOU San Luigi di Orbassano

Bellantonio P; Totaro R; Vianello M; Cavalla P; Granella F; Di Sapio A; Bertolotto A; Maimone D; Bergamaschi R; Lus G; Solaro C; Amato MP; Rovaris M; Gasperini C; Ferrò MT; Pesci I; Aguglia U; Maniscalco GT; Sola P; Conte A; De Luca G; Cottone S; Salemi G; Lugaresi A; Inglese M; Bonavita S; Grimaldi LM; Marfia GA; Brescia Morra V; et alii...

Viability of a MSQOL-54 general health-related quality of life score using bifactor model. in Health and quality of life outcomes / Health Qual Life Outcomes. 2021 Sep 25;19(1):224. doi: 10.1186/s12955-021-01857-y.
2021
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Zaffaroni M; Nocentini U; Ferriani E; Lugaresi A; Grasso MG; Cocco E; Giovannetti AM; Confalonieri P; Viterbo RG; Allegri B; Niccolai C; Grobberio M; Falautano M; Pietrolongo E; Quartuccio ME; Bertolotto A; Cilia S; Bassi M; Testa S; Giordano A; De Livera A; Jelinek G; Solari A; Rosato R;

Serum neurofilament light chain levels in healthy individuals: A proposal of cut-off values for use in multiple sclerosis clinical practice. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2021 Sep;54:103090. doi: 10.1016/j.msard.2021.103090. Epub 2021 Jun 17.
2021
AOU San Luigi di Orbassano

Valentino P; Marnetto F; Martire S; Malucchi S; Bava CI; Popovic M; Bertolotto A;

Fingolimod as first-line treatment in pediatric-onset multiple sclerosis: a case report. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2021 May;42(Suppl 1):25-28. doi: 10.1007/s10072-020-05027-8. Epub 2021 Mar 12.
2021
AOU San Luigi di Orbassano

Capobianco M; Bertolotto A; Malucchi S;

Exposure to fine particulate matter (PM(2.5)) hampers myelin repair in a mouse model of white matter demyelination. in Neurochemistry international / Neurochem Int. 2021 May;145:104991. doi: 10.1016/j.neuint.2021.104991. Epub 2021 Feb 12.
2021
AOU San Luigi di Orbassano

Parolisi R; Montarolo F; Pini A; Rovelli S; Cattaneo A; Bertolotto A; Buffo A; Bollati V; Boda E;

A First Phenotypic and Functional Characterization of Placental Extracellular Vesicles from Women with Multiple Sclerosis. in International journal of molecular sciences / Int J Mol Sci. 2021 Mar 12;22(6):2875. doi: 10.3390/ijms22062875.
2021
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Botta G; Camussi G; Deregibus MC; Chiabotto G; Bruno S; Frezet F; Marozio L; Sforza ML; Perga S; Spadaro M; Montarolo F; Martire S; Benedetto C; Bertolotto A;

Coverage of the requirements of first and second level stroke unit in Italy. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2021 Mar;42(3):1073-1079. doi: 10.1007/s10072-020-04616-x. Epub 2020 Jul 31.
2021
AOU San Luigi di Orbassano

Bandettini di Poggio M; Toni D; Gandolfo C; Paolicelli D; Zini A; Agostoni E; Bandini F; Ragno M; Altavista MC; Bertolotto A; Siciliano G; Vecchio M; Tambasco N; Gambardella A; Manganotti P; Melis M; Onofrj M; De Michele G; Reale N; Tedeschi G; Mancardi G; Bandettini di Poggio M; Toni D; Gandolfo C; Paolicelli D; Zini A; Agostoni E; Bandini F; Ragno M; et alii...

Overexpression of the ubiquitin-editing enzyme A20 in the brain lesions of Multiple Sclerosis patients: moving from systemic to central nervous system inflammation. in Brain pathology (Zurich, Switzerland) / Brain Pathol. 2021 Mar;31(2):283-296. doi: 10.1111/bpa.12906. Epub 2020 Nov 18.
2021
AOU San Luigi di Orbassano

Perga S; Montarolo F; Martire S; Bonaldo B; Bono G; Bertolo J; Magliozzi R; Bertolotto A; Perga S; Montarolo F; Martire S; Bonaldo B; Bono G; Bertolo J; Magliozzi R; Bertolotto A;

Long-term Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis. in Neurology / Neurology. 2021 Feb 22;96(8):e1215-e1226. doi: 10.1212/WNL.0000000000011461.
2021
AOU San Luigi di Orbassano

Boffa G; Massacesi L; Inglese M; Mariottini A; Capobianco M; Moiola L; Amato MP; Cottone S; Gualandi F; De Gobbi M; Greco R; Scimè R; Frau J; Zimatore GB; Bertolotto A; Comi G; Uccelli A; Signori A; Angelucci E; Innocenti C; Ciceri F; Repice AM; Sormani MP; Saccardi R; Mancardi G;

Analysis of the Gadolinium retention in the Experimental Autoimmune Encephalomyelitis (EAE) murine model of Multiple Sclerosis. in Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS) / J Trace Elem Med Biol. 2021 Dec;68:126831. doi: 10.1016/j.jtemb.2021.126831. Epub 2021 Aug 2.
2021
AOU San Luigi di Orbassano

Furlan C; Montarolo F; Di Gregorio E; Parolisi R; Atlante S; Buffo A; Bertolotto A; Aime S; Gianolio E;

HGF and MET: From Brain Development to Neurological Disorders. in Frontiers in cell and developmental biology / Front Cell Dev Biol. 2021 Jun 9;9:683609. doi: 10.3389/fcell.2021.683609. eCollection 2021.
2021
AOU San Luigi di Orbassano

Desole C; Gallo S; Vitacolonna A; Montarolo F; Bertolotto A; Vivien D; Comoglio P; Crepaldi T;

Concomitant brain arterial and venous thrombosis in a COVID-19 patient. in European journal of neurology / Eur J Neurol. 2020 Sep;27(9):e38-e39. doi: 10.1111/ene.14380. Epub 2020 Jun 30.
2020
AOU San Luigi di Orbassano

Malentacchi M; Gned D; Angelino V; Demichelis S; Perboni A; Veltri A; Bertolotto A; Capobianco M;

Proportion of alemtuzumab-treated patients converting from relapsing-remitting multiple sclerosis to secondary progressive multiple sclerosis over 6 years. in Multiple sclerosis journal - experimental, translational and clinical / Mult Scler J Exp Transl Clin. 2020 Dec 18;6(4):2055217320972137. doi: 10.1177/2055217320972137. eCol
2020
AOU San Luigi di Orbassano

Horáková D; Boster A; Bertolotto A; Freedman MS; Firmino I; Cavalier SJ; Jacobs AK; Thangavelu K; Daizadeh N; Poole EM; Baker DP; Margolin DH; Ziemssen T;

Effectiveness of fingolimod in real-world relapsing-remitting multiple sclerosis Italian patients: the GENIUS study. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2020 Oct;41(10):2843-2851. doi: 10.1007/s10072-020-04380-y. Epub 2020 Apr 21.
2020
AOU San Luigi di Orbassano

Comi G; Pozzilli C; Morra VB; Bertolotto A; Sangalli F; Prosperini L; Carotenuto A; Iaffaldano P; Capobianco M; Colombo D; Nica M; Rizzoli S; Trojano M;

In vivo silencing of miR-125a-3p promotes myelin repair in models of white matter demyelination. in Glia / Glia. 2020 Oct;68(10):2001-2014. doi: 10.1002/glia.23819. Epub 2020 Mar 12.
2020
AOU San Luigi di Orbassano

Marangon D; Boda E; Parolisi R; Negri C; Giorgi C; Montarolo F; Perga S; Bertolotto A; Buffo A; Abbracchio MP; Lecca D;

Benign SARS-CoV-2 infection in MOG-antibodies associated disorder during tocilizumab treatment. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2020 Nov;46:102592. doi: 10.1016/j.msard.2020.102592. Epub 2020 Oct 21.
2020
AOU San Luigi di Orbassano

Masuccio FG; Lo Re M; Bertolotto A; Capobianco M; Solaro C;

The transcription factor Nurr1 is upregulated in amyotrophic lateral sclerosis patients and SOD1-G93A mice. in Disease models & mechanisms / Dis Model Mech. 2020 May 15;13(5):dmm043513. doi: 10.1242/dmm.043513.
2020
AOU San Luigi di Orbassano

Valsecchi V; Boido M; Montarolo F; Guglielmotto M; Perga S; Martire S; Cutrupi S; Iannello A; Gionchiglia N; Signorino E; Calvo A; Fuda G; Chiò A; Bertolotto A; Vercelli A;

Assessing measurement invariance of MSQOL-54 across Italian and English versions. in Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation / Qual Life Res. 2020 Mar;29(3):783-791. doi: 10.1007/s11136-019-02352-0. Epub 2019 Nov 9.
2020
AOU San Luigi di Orbassano

Zaffaroni M; Nocentini U; Ferriani E; Lugaresi A; Grasso MG; Cocco E; Giovannetti AM; Confalonieri P; Viterbo RG; Allegri B; Niccolai C; Grobberio M; Falautano M; Pietrolongo E; Quartuccio ME; Bertolotto A; Cilia S; Bassi M; Testa S; Giordano A; De Livera A; Jelinek G; Solari A; Rosato R;

Autologous Hematopoietic Stem Cell Transplantation (AHSCT): Standard of Care for Relapsing-Remitting Multiple Sclerosis Patients. in Neurology and therapy / Neurol Ther. 2020 Dec;9(2):197-203. doi: 10.1007/s40120-020-00200-9. Epub 2020 Jun 16.
2020
AOU San Luigi di Orbassano

Bertolotto A; Martire S; Mirabile L; Capobianco M; De Gobbi M; Cilloni D;

2020
AOU San Luigi di Orbassano

Bertolotto A; Arroyo R; Celius EG; Comi G; Havrdova EK; Honeycutt WD; Hunter SF; Izquierdo G; Kornek B; Miller T; Mitsikostas DD; Singer BA; Ziemssen T; Chung L; Daizadeh N; Afsar S; Hashemi L; Senior P;

TNFAIP3 Deficiency Affects Monocytes, Monocytes-Derived Cells and Microglia in Mice. in International journal of molecular sciences / Int J Mol Sci. 2020 Apr 18;21(8):2830. doi: 10.3390/ijms21082830.
2020
AOU San Luigi di Orbassano

Montarolo F; Perga S; Tessarolo C; Spadaro M; Martire S; Bertolotto A;

NURR1 Impairment in Multiple Sclerosis. in International journal of molecular sciences / Int J Mol Sci. 2019 Sep 30;20(19):4858. doi: 10.3390/ijms20194858.
2019
AOU San Luigi di Orbassano

Montarolo F; Martire S; Perga S; Bertolotto A;

eMSQOL-29: Prospective validation of the abbreviated, electronic version of MSQOL-54. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2019 May;25(6):856-866. doi: 10.1177/1352458518774935. Epub 2018 May 15.
2019
AOU San Luigi di Orbassano

Rosato R; Testa S; Bertolotto A; Scavelli F; Giovannetti AM; Confalonieri P; Patti F; Chisari CG; Lugaresi A; Pietrolongo E; Grasso MG; Rossi I; Toscano A; Loera B; Giordano A; Solari A;

Long-term follow-up of pediatric MS patients starting treatment with injectable first-line agents: A multicentre, Italian, retrospective, observational study. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2019 Mar;25(3):399-407. doi: 10.1177/1352458518754364. Epub 2018 Jan 24.
2019
AOU San Luigi di Orbassano

Baroncini D; Zaffaroni M; Moiola L; Lorefice L; Fenu G; Iaffaldano P; Simone M; Fanelli F; Patti F; D'Amico E; Capobianco M; Bertolotto A; Gallo P; Margoni M; Miante S; Milani N; Amato MP; Righini I; Bellantonio P; Scandellari C; Costantino G; Scarpini E; Bergamaschi R; Mallucci G; Comi G; Ghezzi A;

NURR1 deficiency is associated to ADHD-like phenotypes in mice. in Translational psychiatry / Transl Psychiatry. 2019 Aug 27;9(1):207. doi: 10.1038/s41398-019-0544-0.
2019
AOU San Luigi di Orbassano

Montarolo F; Martire S; Perga S; Spadaro M; Brescia I; Allegra S; De Francia S; Bertolotto A;

Study of the NR4A family gene expression in patients with multiple sclerosis treated with Fingolimod. in European journal of neurology / Eur J Neurol. 2019 Apr;26(4):667-672. doi: 10.1111/ene.13875. Epub 2018 Dec 22.
2019
AOU San Luigi di Orbassano

Montarolo F; Perga S; Martire S; Brescia F; Caldano M; Lo Re M; Panzica G; Bertolotto A;

Best Practices for Long-Term Monitoring and Follow-Up of Alemtuzumab-Treated MS Patients in Real-World Clinical Settings. in Frontiers in neurology / Front Neurol. 2019 Mar 22;10:253. doi: 10.3389/fneur.2019.00253. eCollection 2019.
2019
AOU San Luigi di Orbassano

Barclay K; Carruthers R; Traboulsee A; Bass AD; LaGanke C; Bertolotto A; Boster A; Celius EG; de Seze J; Cruz DD; Habek M; Lee JM; Limmroth V; Meuth SG; Oreja-Guevara C; Pagnotta P; Vos C; Ziemssen T; Baker DP; Wijmeersch BV;

Rituximab-induced hypogammaglobulinemia in patients with neuromyelitis optica spectrum disorders. in Neurology(R) neuroimmunology & neuroinflammation / Neurol Neuroimmunol Neuroinflamm. 2018 Sep 13;5(6):e498. doi: 10.1212/NXI.0000000000000498. eCollect
2018
AOU San Luigi di Orbassano

Marcinnò A; Marnetto F; Valentino P; Martire S; Balbo A; Drago A; Leto M; Capobianco M; Panzica G; Bertolotto A;

Correction to: Management of pregnancy-related issues in multiple sclerosis patients: the need for an interdisciplinary approach. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2018 Feb;39(2):395. doi: 10.1007/s10072-017-3226-9.
2018
AOU San Luigi di Orbassano

Amato MP; Bertolotto A; Brunelli R; Cavalla P; Goretti B; Marrosu MG; Patti F; Pozzilli C; Provinciali L; Rizzo N; Strobelt N; Tedeschi G; Trojano M; Comi G;

Authors' Response to the Letter to the Editor Regarding: A Comprehensive Review on Copemyl(®). in Neurology and therapy / Neurol Ther. 2018 Dec;7(2):391-393. doi: 10.1007/s40120-018-0116-x. Epub 2018 Nov 10.
2018
AOU San Luigi di Orbassano

Annovazzi P; Bertolotto A; Brescia Morra V; Gasperini C; Montanari E; Navarra P; Patti F; Pia Sormani M; Ghezzi A;

Access to social security benefits among multiple sclerosis patients in Italy: A cross-sectional study. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2018 Aug;24:107-112. doi: 10.1016/j.msard.2018.06.016. Epub 2018 Jun 23.
2018
AOU San Luigi di Orbassano

Bo M; Charrier L; Bartalini S; Benvenuti M; Oggero A; Ulivelli M; Gabbrielli M; Bertolotto A; Gianino MM;

Two-year real-life efficacy, tolerability and safety of dimethyl fumarate in an Italian multicentre study. in Journal of neurology / J Neurol. 2018 Aug;265(8):1850-1859. doi: 10.1007/s00415-018-8916-6. Epub 2018 Jun 14.
2018
AOU San Luigi di Orbassano

Mallucci G; Annovazzi P; Miante S; Torri-Clerici V; Matta M; La Gioia S; Cavarretta R; Mantero V; Costantini G; D'Ambrosio V; Zaffaroni M; Ghezzi A; Perini P; Rossi S; Bertolotto A; Rottoli MR; Rovaris M; Balgera R; Cavalla P; Montomoli C; Bergamaschi R;

The Footprints of Poly-Autoimmunity: Evidence for Common Biological Factors Involved in Multiple Sclerosis and Hashimoto's Thyroiditis. in Frontiers in immunology / Front Immunol. 2018 Feb 20;9:311. doi: 10.3389/fimmu.2018.00311. eCollection 2018.
2018
AOU San Luigi di Orbassano

Perga S; Martire S; Montarolo F; Giordani I; Spadaro M; Bono G; Corvisieri S; Messuti I; Panzica G; Orlandi F; Bertolotto A;

Diagnostics of the neuromyelitis optica spectrum disorders (NMOSD). in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2017 Oct;38(Suppl 2):231-236. doi: 10.1007/s10072-017-3027-1.
2017
AOU San Luigi di Orbassano

Franciotta D; Gastaldi M; Sala A; Andreetta F; Rinaldi E; Ruggieri M; Leante R; Costa G; Biagioli T; Massacesi L; Bazzigaluppi E; Fazio R; Mariotto S; Ferrari S; Galloni E; Perini F; Zardini E; Zuliani L; Zoccarato M; Giometto B; Bertolotto A;

Cerebrospinal fluid analysis and the determination of oligoclonal bands. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2017 Oct;38(Suppl 2):217-224. doi: 10.1007/s10072-017-3034-2.
2017
AOU San Luigi di Orbassano

Gastaldi M; Zardini E; Leante R; Ruggieri M; Costa G; Cocco E; De Luca G; Cataldo I; Biagioli T; Ballerini C; Castellazzi M; Fainardi E; Pettini P; Zaffaroni M; Giunti D; Capello E; Bernardi G; Ciusani E; Giannotta C; Nobile-Orazio E; Bazzigaluppi E; Passerini G; Bedin R; Sola P; Brivio R; Cavaletti G; Sala A; Bertolotto A; Desina G; et alii...

Management of pregnancy-related issues in multiple sclerosis patients: the need for an interdisciplinary approach. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2017 Oct;38(10):1849-1858. doi: 10.1007/s10072-017-3081-8. Epub 2017 Aug 2.
2017
AOU San Luigi di Orbassano

Amato MP; Bertolotto A; Brunelli R; Cavalla P; Goretti B; Marrosu MG; Patti F; Pozzilli C; Provinciali L; Rizzo N; Strobelt N; Tedeschi G; Trojano M; Comi G;

Long-term disability progression in primary progressive multiple sclerosis: a 15-year study. in Brain : a journal of neurology / Brain. 2017 Nov 1;140(11):2814-2819. doi: 10.1093/brain/awx250.
2017
AOU San Luigi di Orbassano

Rocca MA; Sormani MP; Rovaris M; Caputo D; Ghezzi A; Montanari E; Bertolotto A; Laroni A; Bergamaschi R; Martinelli V; Comi G; Filippi M;

A multicenter, observational, prospective study of self- and parent-reported quality of life in adolescent multiple sclerosis patients self-administering interferon-?1a using RebiSmart™-the FUTURE study. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2017 Nov;38(11):1999-2005. doi: 10.1007/s10072-017-3091-6. Epub 2017 Aug 22.
2017
AOU San Luigi di Orbassano

Ghezzi A; Bianchi A; Baroncini D; Bertolotto A; Malucchi S; Bresciamorra V; Lanzillo R; Milani N; Martinelli V; Patti F; Chisari C; Rottoli M; Simone M; Paolicelli D; Visconti A;

Computerized posturography is more sensitive than clinical Romberg Test in detecting postural control impairment in minimally impaired Multiple Sclerosis patients. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2017 May;14:51-55. doi: 10.1016/j.msard.2017.03.008. Epub 2017 Mar 23.
2017
AOU San Luigi di Orbassano

Melillo F; Di Sapio A; Martire S; Malentacchi M; Matta M; Bertolotto A;

Aquaporin-4 antibody titration in NMO patients treated with rituximab: A retrospective study. in Neurology(R) neuroimmunology & neuroinflammation / Neurol Neuroimmunol Neuroinflamm. 2016 Dec 15;4(2):e317. doi: 10.1212/NXI.0000000000000317. eCollect
2017
AOU San Luigi di Orbassano

Valentino P; Marnetto F; Granieri L; Capobianco M; Bertolotto A;

High-Risk PML Patients Switching from Natalizumab to Alemtuzumab: an Observational Study. in Neurology and therapy / Neurol Ther. 2017 Jun;6(1):145-152. doi: 10.1007/s40120-016-0058-0. Epub 2016 Dec 3.
2017
AOU San Luigi di Orbassano

Malucchi S; Capobianco M; Lo Re M; Malentacchi M; di Sapio A; Matta M; Sperli F; Bertolotto A;

Detection of potassium channel KIR4.1 antibodies in Multiple Sclerosis patients. in Journal of immunological methods / J Immunol Methods. 2017 Jun;445:53-58. doi: 10.1016/j.jim.2017.03.008. Epub 2017 Mar 12.
2017
AOU San Luigi di Orbassano

Marnetto F; Valentino P; Caldano M; Bertolotto A;

A20 in Multiple Sclerosis and Parkinson's Disease: Clue to a Common Dysregulation of Anti-Inflammatory Pathways? in Neurotoxicity research / Neurotox Res. 2017 Jul;32(1):1-7. doi: 10.1007/s12640-017-9724-y. Epub 2017 Mar 23.
2017
AOU San Luigi di Orbassano

Perga S; Martire S; Montarolo F; Navone ND; Calvo A; Fuda G; Marchet A; Leotta D; Chiò A; Bertolotto A;

Erratum to: Altered NR4A Subfamily Gene Expression Level in Peripheral Blood of Parkinson's and Alzheimer's Disease Patients. in Neurotoxicity research / Neurotox Res. 2017 Feb;31(2):317. doi: 10.1007/s12640-016-9685-6.
2017
AOU San Luigi di Orbassano

Montarolo F; Perga S; Martire S; Navone DN; Marchet A; Leotta D; Bertolotto A;

A Comprehensive Review on Copemyl(®). in Neurology and therapy / Neurol Ther. 2017 Dec;6(2):161-173. doi: 10.1007/s40120-017-0079-3. Epub 2017 Jul 31.
2017
AOU San Luigi di Orbassano

Annovazzi P; Bertolotto A; Brescia Morra V; Gasperini C; Montanari E; Navarra P; Patti F; Sormani MP; Ghezzi A;

Biopharmaceuticals: Reference Products and Biosimilars to Treat Inflammatory Diseases. in Therapeutic drug monitoring / Ther Drug Monit. 2017 Aug;39(4):308-315. doi: 10.1097/FTD.0000000000000385.
2017
AOU San Luigi di Orbassano

Gils A; Bertolotto A; Mulleman D; Bejan-Angoulvant T; Declerck PJ;

Rationale for Therapeutic Drug Monitoring of Biopharmaceuticals in Inflammatory Diseases. in Therapeutic drug monitoring / Ther Drug Monit. 2017 Aug;39(4):339-343. doi: 10.1097/FTD.0000000000000410.
2017
AOU San Luigi di Orbassano

Paintaud G; Passot C; Ternant D; Bertolotto A; Bejan-Angoulvant T; Pascual-Salcedo D; Mulleman D;

Biological activity of glatiramer acetate on Treg and anti-inflammatory monocytes persists for more than 10years in responder multiple sclerosis patients. in Clinical immunology (Orlando, Fla.) / Clin Immunol. 2017 Aug;181:83-88. doi: 10.1016/j.clim.2017.06.006. Epub 2017 Jun 19.
2017
AOU San Luigi di Orbassano

Spadaro M; Montarolo F; Perga S; Martire S; Brescia F; Malucchi S; Bertolotto A;

Role of Anti-Osteopontin Antibodies in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis. in Frontiers in immunology / Front Immunol. 2017 Mar 23;8:321. doi: 10.3389/fimmu.2017.00321. eCollection 2017.
2017
AOU San Luigi di Orbassano

Clemente N; Comi C; Raineri D; Cappellano G; Vecchio D; Orilieri E; Gigliotti CL; Boggio E; Dianzani C; Sorosina M; Martinelli-Boneschi F; Caldano M; Bertolotto A; Ambrogio L; Sblattero D; Cena T; Leone M; Dianzani U; Chiocchetti A;

The Effectiveness of a Body-Affective Mindfulness Intervention for Multiple Sclerosis Patients with Depressive Symptoms: A Randomized Controlled Clinical Trial. in Frontiers in psychology / Front Psychol. 2017 Nov 30;8:2083. doi: 10.3389/fpsyg.2017.02083. eCollection 2017.
2017
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Torta R; Oliva F; Bertolotto A; Malucchi S; Bertino G; Scavelli F; Francone D; Tesio V; Borghi M; Carletto S; Ostacoli L; Carletto S; Tesio V; Borghi M; Francone D; Scavelli F; Bertino G; Malucchi S; Bertolotto A; Oliva F; Torta R; Ostacoli L;

Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica. in Journal of neurology, neurosurgery, and psychiatry / J Neurol Neurosurg Psychiatry. 2016 Sep;87(9):1005-15. doi: 10.1136/jnnp-2015-312601. Epub 2016 Apr
2016
AOU San Luigi di Orbassano

Waters P; Reindl M; Saiz A; Schanda K; Tuller F; Kral V; Nytrova P; Sobek O; Nielsen HH; Barington T; Lillevang ST; Illes Z; Rentzsch K; Berthele A; Berki T; Granieri L; Bertolotto A; Giometto B; Zuliani L; Hamann D; van Pelt ED; Hintzen R; Höftberger R; Costa C; Comabella M; Montalban X; Tintoré M; Siva A; Altintas A; et alii...

Altered NR4A Subfamily Gene Expression Level in Peripheral Blood of Parkinson's and Alzheimer's Disease Patients. in Neurotoxicity research / Neurotox Res. 2016 Oct;30(3):338-44. doi: 10.1007/s12640-016-9626-4. Epub 2016 May 9.
2016
AOU San Luigi di Orbassano

Montarolo F; Perga S; Martire S; Navone DN; Marchet A; Leotta D; Bertolotto A;

A gene expression study denies the ability of 25 candidate biomarkers to predict the interferon-beta treatment response in multiple sclerosis patients. in Journal of neuroimmunology / J Neuroimmunol. 2016 Mar 15;292:34-9. doi: 10.1016/j.jneuroim.2016.01.010. Epub 2016 Jan 16.
2016
AOU San Luigi di Orbassano

Martire S; Navone ND; Montarolo F; Perga S; Bertolotto A;

PML risk stratification using anti-JCV antibody index and L-selectin. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2016 Jul;22(8):1048-60. doi: 10.1177/1352458515607651. Epub 2015 Oct 2.
2016
AOU San Luigi di Orbassano

Comabella M; Kleinschnitz C; Jacobi A; Du Pasquier RA; Gold R; Zipp F; Meuth SG; Posevitz-Fejfár A; Montalban X; Luessi F; Siffrin V; Hohlfeld R; Kümpfel T; Cantó E; Breuer J; Windhagen S; Tackenberg B; Meinl I; Görlich D; Pignolet B; Spadaro M; Schneider-Hohendorf T; Schwab N; Bertolotto A; Brassat D; Wiendl H;

2016
ASL Torino 3
AOU San Luigi di Orbassano

Oliva F; Bertolotto A; Malucchi S; Cavallo M; Bertino G; Scavelli F; Francone D; Borghi M; Carletto S; Ostacoli L;

Reversible disconnection syndrome in a case of acute tumefactive demyelinating lesion: a PET study. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2016 Dec;37(12):2019-2023. doi: 10.1007/s10072-016-2675-x. Epub 2016 Jul 25.
2016
AOU San Luigi di Orbassano

Chiavazza C; Cistaro A; Fania P; Bertolotto A; Cavalla P; Rudà R; Pinessi L; Soffietti R;

Cytokine profiles show heterogeneity of interferon-? response in multiple sclerosis patients. in Neurology(R) neuroimmunology & neuroinflammation / Neurol Neuroimmunol Neuroinflamm. 2016 Jan 27;3(2):e202. doi: 10.1212/NXI.0000000000000202. eCollect
2016
AOU San Luigi di Orbassano

Hegen H; Adrianto I; Lessard CJ; Millonig A; Bertolotto A; Comabella M; Giovannoni G; Guger M; Hoelzl M; Khalil M; Fazekas F; Killestein J; Lindberg RL; Malucchi S; Mehling M; Montalban X; Rudzki D; Schautzer F; Sellebjerg F; Sorensen PS; Deisenhammer F; Steinman L; Axtell RC;

Anal sphincter dysfunction in multiple sclerosis: an observation manometric study. in Open medicine (Warsaw, Poland) / Open Med (Wars). 2016 Nov 25;11(1):509-517. doi: 10.1515/med-2016-0088. eCollection 2016.
2016
AOU San Luigi di Orbassano

Marola S; Ferrarese A; Gibin E; Capobianco M; Bertolotto A; Enrico S; Solej M; Martino V; Destefano I; Nano M;

2016
AOU San Luigi di Orbassano

Troni W; Melillo F; Bertolotto A; Malucchi S; Capobianco M; Sperli F; Di Sapio A;

Development of a Short Version of MSQOL-54 Using Factor Analysis and Item Response Theory. in PloS one / PLoS One. 2016 Apr 14;11(4):e0153466. doi: 10.1371/journal.pone.0153466. eCollection 2016.
2016
AOU San Luigi di Orbassano

Rosato R; Testa S; Bertolotto A; Confalonieri P; Patti F; Lugaresi A; Grasso MG; Toscano A; Giordano A; Solari A;

Decline of Neuropsychological Abilities in a Large Sample of Patients with Multiple Sclerosis: A Two-Year Longitudinal Study. in Frontiers in human neuroscience / Front Hum Neurosci. 2016 Jun 8;10:282. doi: 10.3389/fnhum.2016.00282. eCollection 2016.
2016
AOU San Luigi di Orbassano

Borghi M; Carletto S; Ostacoli L; Scavelli F; Pia L; Pagani M; Bertolotto A; Malucchi S; Signori A; Cavallo M;

Evaluation of the impact of neutralizing antibodies on IFN? response. in Clinica chimica acta; international journal of clinical chemistry / Clin Chim Acta. 2015 Sep 20;449:31-6. doi: 10.1016/j.cca.2015.02.043. Epub 2015 Mar 10.
2015
AOU San Luigi di Orbassano

Bertolotto A;

Nurr1 reduction influences the onset of chronic EAE in mice. in Inflammation research : official journal of the European Histamine Research Society ... [et al.] / Inflamm Res. 2015 Nov;64(11):841-4. doi: 10.1007/s00011-015-0871-4. Epub 2015 Sep 4.
2015
AOU San Luigi di Orbassano

Montarolo F; Perga S; Martire S; Bertolotto A;

Fingolimod versus interferon beta/glatiramer acetate after natalizumab suspension in multiple sclerosis. in Brain : a journal of neurology / Brain. 2015 Nov;138(Pt 11):3275-86. doi: 10.1093/brain/awv260. Epub 2015 Sep 11.
2015
AOU San Luigi di Orbassano

Iaffaldano P; Lucisano G; Pozzilli C; Brescia Morra V; Ghezzi A; Millefiorini E; Patti F; Lugaresi A; Zimatore GB; Marrosu MG; Amato MP; Bertolotto A; Bergamaschi R; Granella F; Coniglio G; Tedeschi G; Sola P; Lus G; Ferrò MT; Iuliano G; Corea F; Protti A; Cavalla P; Guareschi A; Rodegher M; Paolicelli D; Tortorella C; Lepore V; Prosperini L; et alii...

2015
AOU San Luigi di Orbassano

Capobianco M; di Sapio A; Malentacchi M; Malucchi S; Matta M; Sperli F; Bertolotto A;

Peculiar Cytological Cerebrospinal Fluid Pattern in a Case of Encephalomyelitis During Anti-Tumor Necrosis Factor-? Therapy. in Neurology and therapy / Neurol Ther. 2015 Jun;4(1):53-60. doi: 10.1007/s40120-015-0027-z. Epub 2015 Mar 6.
2015
AOU San Luigi di Orbassano

Motuzova Y; Di Sapio A; Capobianco M; Sala A; Marnetto F; Malucchi S; Bertolotto A;

2015
AOU San Luigi di Orbassano

Veroni C; Marnetto F; Granieri L; Bertolotto A; Ballerini C; Repice AM; Schirru L; Coghe G; Cocco E; Anastasiadou E; Puopolo M; Aloisi F;

Anti-inflammatory genes associated with multiple sclerosis: a gene expression study. in Journal of neuroimmunology / J Neuroimmunol. 2015 Feb 15;279:75-8. doi: 10.1016/j.jneuroim.2015.01.004. Epub 2015 Jan 21.
2015
AOU San Luigi di Orbassano

Perga S; Montarolo F; Martire S; Berchialla P; Malucchi S; Bertolotto A;

Natalizumab Discontinuation and Treatment Strategies in Patients with Multiple Sclerosis (MS): A Retrospective Study from Two Italian MS Centers. in Neurology and therapy / Neurol Ther. 2015 Dec;4(2):147-57. doi: 10.1007/s40120-015-0038-9. Epub 2015 Dec 8.
2015
AOU San Luigi di Orbassano

Lo Re M; Capobianco M; Ragonese P; Realmuto S; Malucchi S; Berchialla P; Salemi G; Bertolotto A;

Natalizumab treatment reduces L-selectin (CD62L) in CD4+ T cells. in Journal of neuroinflammation / J Neuroinflammation. 2015 Aug 12;12:146. doi: 10.1186/s12974-015-0365-x.
2015
AOU San Luigi di Orbassano

Spadaro M; Caldano M; Marnetto F; Lugaresi A; Bertolotto A;

Biological monitoring of IFN-? therapy in Multiple Sclerosis. in Cytokine & growth factor reviews / Cytokine Growth Factor Rev. 2015 Apr;26(2):241-8. doi: 10.1016/j.cytogfr.2014.12.002. Epub 2014 Dec
2015
AOU San Luigi di Orbassano

Bertolotto A; Granieri L; Marnetto F; Valentino P; Sala A; Capobianco M; Malucchi S; Di Sapio A; Malentacchi M; Matta M; Caldano M;

Vitamin D Binding Protein Isoforms and Apolipoprotein E in Cerebrospinal Fluid as Prognostic Biomarkers of Multiple Sclerosis. in PloS one / PLoS One. 2015 Jun 5;10(6):e0129291. doi: 10.1371/journal.pone.0129291. eCollection 2015.
2015
AOU San Luigi di Orbassano

Perga S; Giuliano Albo A; Lis K; Minari N; Falvo S; Marnetto F; Caldano M; Reviglione R; Berchialla P; Capobianco MA; Malentacchi M; Corpillo D; Bertolotto A;

Monocytes and CD4+ T cells contribution to the under-expression of NR4A2 and TNFAIP3 genes in patients with multiple sclerosis. in Journal of neuroimmunology / J Neuroimmunol. 2014 Jul 15;272(1-2):99-102. doi: 10.1016/j.jneuroim.2014.04.017. Epub 2014 May 10.
2014
AOU San Luigi di Orbassano

Navone ND; Perga S; Martire S; Berchialla P; Malucchi S; Bertolotto A;

A new neurophysiological approach to assess central motor conduction damage to proximal and distal muscles of lower limbs. in Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology / Clin Neurophysiol. 2014 Jan;125(1):133-41. doi: 10.1016/j.clinph.2013.06.018. Epub 2013 Jul 16.
2014
AOU San Luigi di Orbassano

Di Sapio A; Bertolotto A; Melillo F; Sperli F; Malucchi S; Troni W; Di Sapio A; Bertolotto A; Melillo F; Sperli F; Malucchi S; Troni W;

Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2014 Feb;35(2):307-16. doi: 10.1007/s10072-013-1616-1. Epub 2013 Dec 29.
2014
AOU San Luigi di Orbassano

Bertolotto A; Capobianco M; Amato MP; Capello E; Capra R; Centonze D; Di Ioia M; Gallo A; Grimaldi L; Imberti L; Lugaresi A; Mancinelli C; Marrosu MG; Moiola L; Montanari E; Romano S; Musu L; Paolicelli D; Patti F; Pozzilli C; Rossi S; Salvetti M; Tedeschi G; Tola MR; Trojano M; Zaffaroni M; Malucchi S; Bertolotto A; Capobianco M; et alii...

CD19 mRNA quantification improves rituximab treatment-to-target approach: a proof of concept study. in Journal of neuroimmunology / J Neuroimmunol. 2014 Dec 15;277(1-2):127-33. doi: 10.1016/j.jneuroim.2014.09.008. Epub 2014 Sep 20.
2014
AOU San Luigi di Orbassano

Marnetto F; Granieri L; Valentino P; Capobianco M; Pautasso M; Bertolotto A;

Multiple Sclerosis State of the Art (SMART): A Qualitative and Quantitative Analysis of Therapy's Adherence, Hospital Reliability's Perception, and Services Provided Quality. in Multiple sclerosis international / Mult Scler Int. 2014;2014:752318. doi: 10.1155/2014/752318. Epub 2014 Aug 26.
2014
AOU San Luigi di Orbassano

Di Battista G; Bertolotto A; Gasperini C; Ghezzi A; Maimone D; Solaro C;

Effects of isoxazolo-pyridinone 7e, a potent activator of the Nurr1 signaling pathway, on experimental autoimmune encephalomyelitis in mice. in PloS one / PLoS One. 2014 Sep 29;9(9):e108791. doi: 10.1371/journal.pone.0108791. eCollection 2014.
2014
AOU San Luigi di Orbassano

Montarolo F; Raffaele C; Perga S; Martire S; Finardi A; Furlan R; Hintermann S; Bertolotto A;

Prevalence and significant determinants of post-traumatic stress disorder in a large sample of patients with multiple sclerosis. in Journal of clinical psychology in medical settings / J Clin Psychol Med Settings. 2013 Jun;20(2):240-6. doi: 10.1007/s10880-012-9323-2.
2013
ASL Torino 3
AOU San Luigi di Orbassano

Carletto S; Borghi M; Cavallo M; Ostacoli L; Rocci E; Zuffranieri M; Malucchi S; Bertolotto A; Zennaro A; Furlan PM; Picci RL;

Presence and significant determinants of cognitive impairment in a large sample of patients with multiple sclerosis. in PloS one / PLoS One. 2013 Jul 29;8(7):e69820. doi: 10.1371/journal.pone.0069820. Print 2013.
2013
ASL Torino 3
AOU San Luigi di Orbassano

Carletto S; Ostacoli L; Zuffranieri M; Cavallo M; Borghi M; Picci RL; Scavelli F; Johnston H; Furlan PM; Bertolotto A; Malucchi S;

Classification of individuals based on ex-vivo glatiramer acetate-induced interferon-? and interleukin-4 response. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2012 Oct;18(10):1484-92. doi: 10.1177/1352458512440349. Epub 2012 May 4.
2012
AOU San Luigi di Orbassano

Gilli F; Navone ND; Valentino P; Granieri L; Perga S; Malucchi S; Bertolotto A;

Natalizumab in aggressive multiple sclerosis after haematopoietic stem cell transplantation. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2012 Aug;33(4):863-7. doi: 10.1007/s10072-011-0848-1. Epub 2011 Nov 25.
2012
AOU San Luigi di Orbassano

Capobianco M; Motuzova Y; Frau J; Cocco E; Mamusa E; Marrosu MG; Bertolotto A;

Evaluation of a multiparametric immunofluorescence assay for standardization of neuromyelitis optica serology. in PloS one / PLoS One. 2012;7(6):e38896. doi: 10.1371/journal.pone.0038896. Epub 2012 Jun 12.
2012
AOU San Luigi di Orbassano

Granieri L; Marnetto F; Valentino P; Frau J; Patanella AK; Nytrova P; Sola P; Capobianco M; Jarius S; Bertolotto A;

A methodological reappraisal of non invasive high voltage electrical stimulation of lumbosacral nerve roots. in Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology / Clin Neurophysiol. 2011 Oct;122(10):2071-80. doi: 10.1016/j.clinph.2011.03.002. Epub 2011 Mar 31.
2011
AOU San Luigi di Orbassano

Troni W; Di Sapio A; Berra E; Duca S; Merola A; Sperli F; Bertolotto A;

One-year evaluation of factors affecting the biological activity of interferon beta in multiple sclerosis patients. in Journal of neurology / J Neurol. 2011 May;258(5):895-903. doi: 10.1007/s00415-010-5844-5. Epub 2010 Dec 12.
2011
AOU San Luigi di Orbassano

Malucchi S; Gilli F; Caldano M; Sala A; Capobianco M; di Sapio A; Granieri L; Bertolotto A;

Loss of braking signals during inflammation: a factor affecting the development and disease course of multiple sclerosis. in Archives of neurology / Arch Neurol. 2011 Jul;68(7):879-88. doi: 10.1001/archneurol.2011.32. Epub 2011 Mar 14.
2011
AOU San Luigi di Orbassano

Gilli F; Navone ND; Perga S; Marnetto F; Caldano M; Capobianco M; Pulizzi A; Malucchi S; Bertolotto A;

Learning from nature: pregnancy changes the expression of inflammation-related genes in patients with multiple sclerosis. in PloS one / PLoS One. 2010 Jan 29;5(1):e8962. doi: 10.1371/journal.pone.0008962.
2010
AOU San Luigi di Orbassano

Gilli F; Lindberg RL; Valentino P; Marnetto F; Malucchi S; Sala A; Capobianco M; di Sapio A; Sperli F; Kappos L; Calogero RA; Bertolotto A;

Implications of neutralising antibodies on therapeutic efficacy. in Journal of the neurological sciences / J Neurol Sci. 2009 Feb 1;277 Suppl 1:S29-32. doi: 10.1016/S0022-510X(09)70009-7.
2009
AOU San Luigi di Orbassano

Bertolotto A;

Western blot analysis for the detection of serum antibodies recognizing linear Aquaporin-4 epitopes in patients with Neuromyelitis Optica. in Journal of neuroimmunology / J Neuroimmunol. 2009 Dec 10;217(1-2):74-9. doi: 10.1016/j.jneuroim.2009.10.002. Epub 2009 Oct 21.
2009
AOU San Luigi di Orbassano

Marnetto F; Hellias B; Granieri L; Frau J; Patanella AK; Nytrova P; Sala A; Capobianco M; Gilli F; Bertolotto A;

Interferon-beta responders and non-responders. A biological approach. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2008 Sep;29 Suppl 2:S216-7. doi: 10.1007/s10072-008-0941-2.
2008
AOU San Luigi di Orbassano

Bertolotto A; Gilli F;

Glatiramer acetate is a treatment option in neutralising antibodies to interferon-beta-positive patients. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2008 Sep;29 Suppl 2:S227-9. doi: 10.1007/s10072-008-0945-y.
2008
AOU San Luigi di Orbassano

Capobianco M; Rizzo A; Malucchi S; Sperli F; Di Sapio A; Oggero A; Zaffaroni M; Ghezzi A; Bertolotto A;

Predictive markers for response to interferon therapy in patients with multiple sclerosis. in Neurology / Neurology. 2008 Mar 25;70(13 Pt 2):1119-27. doi: 10.1212/01.wnl.0000304040.29080.7b. Epub 2008 Feb 1
2008
AOU San Luigi di Orbassano

Malucchi S; Gilli F; Caldano M; Marnetto F; Valentino P; Granieri L; Sala A; Capobianco M; Bertolotto A;

Acute myeloid leukemia induced by mitoxantrone treatment for aggressive multiple sclerosis. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2008 Jun;29(3):185-7. doi: 10.1007/s10072-008-0934-1. Epub 2008 Jul 9.
2008
AOU San Luigi di Orbassano

Capobianco M; Malucchi S; Ulisciani S; Fava C; Cambrin GR; Avonto L; Saglio G; Bertolotto A;

Development of a bioassay for quantification of neutralising antibodies against human interferon-beta in mouse sera. in Journal of immunological methods / J Immunol Methods. 2008 Jul 31;336(2):119-26. doi: 10.1016/j.jim.2008.04.002. Epub 2008 Apr 28.
2008
AOU San Luigi di Orbassano

Gilli F; van Beers M; Marnetto F; Jiskoot W; Bertolotto A; Schellekens H;

Expression and regulation of IFNalpha/beta receptor in IFNbeta-treated patients with multiple sclerosis. in Neurology / Neurology. 2008 Dec 9;71(24):1940-7. doi: 10.1212/01.wnl.0000327340.50284.8d. Epub 2008 Oct 29.
2008
AOU San Luigi di Orbassano

Gilli F; Valentino P; Caldano M; Granieri L; Capobianco M; Malucchi S; Sala A; Marnetto F; Bertolotto A;

Anti-interferon-beta neutralising activity is not entirely mediated by antibodies. in Journal of neuroimmunology / J Neuroimmunol. 2007 Dec;192(1-2):198-205. doi: 10.1016/j.jneuroim.2007.09.025. Epub 2007 Oct 22.
2007
AOU San Luigi di Orbassano

Gilli F; Marnetto F; Caldano M; Valentino P; Granieri L; Di Sapio A; Capobianco M; Sala A; Malucchi S; Kappos L; Lindberg RL; Bertolotto A;

Variable responses to rituximab treatment in neuromyelitis optica (Devic's disease). in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2007 Aug;28(4):209-11. doi: 10.1007/s10072-007-0823-z. Epub 2007 Aug 10.
2007
AOU San Luigi di Orbassano

Capobianco M; Malucchi S; di Sapio A; Gilli F; Sala A; Bottero R; Marnetto F; Doriguzzi Bozzo C; Bertolotto A;

Development and validation of a real time PCR-based bioassay for quantification of neutralizing antibodies against human interferon-beta. in Journal of immunological methods / J Immunol Methods. 2007 Apr 10;321(1-2):19-31. doi: 10.1016/j.jim.2006.12.012. Epub 2007 Feb 20.
2007
AOU San Luigi di Orbassano

Bertolotto A; Sala A; Caldano M; Capobianco M; Malucchi S; Marnetto F; Gilli F;

Biological markers of interferon-beta therapy: comparison among interferon-stimulated genes MxA, TRAIL and XAF-1. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2006 Feb;12(1):47-57. doi: 10.1191/135248506ms1245oa.
2006
AOU San Luigi di Orbassano

Gilli F; Marnetto F; Caldano M; Sala A; Malucchi S; Capobianco M; Bertolotto A;

Qualitative and quantitative analysis of antibody response against IFNbeta in patients with multiple sclerosis. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2006 Dec;12(6):738-46. doi: 10.1177/1352458506070968.
2006
AOU San Luigi di Orbassano

Gilli F; Hoffmann F; Sala A; Marnetto F; Caldano M; Valentino P; Kappos L; Bertolotto A; Lindberg RL;

Biological responsiveness to first injections of interferon-beta in patients with multiple sclerosis. in Journal of neuroimmunology / J Neuroimmunol. 2005 Jan;158(1-2):195-203. doi: 10.1016/j.jneuroim.2004.08.006.
2005
AOU San Luigi di Orbassano

Gilli F; Marnetto F; Caldano M; Sala A; Malucchi S; Di Sapio A; Capobianco M; Bertolotto A;

Fate of multiple sclerosis patients positive for neutralising antibodies towards interferon beta shifted to alternative treatments. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2005 Dec;26 Suppl 4:S213-4. doi: 10.1007/s10072-005-0517-3.
2005
AOU San Luigi di Orbassano

Malucchi S; Capobianco M; Gilli F; Marnetto F; Caldano M; Sala A; Bertolotto A;

Biological activity of interferon betas in patients with multiple sclerosis is affected by treatment regimen and neutralising antibodies. in Journal of neurology, neurosurgery, and psychiatry / J Neurol Neurosurg Psychiatry. 2004 Sep;75(9):1294-9. doi: 10.1136/jnnp.2004.037259.
2004
AOU San Luigi di Orbassano

Bertolotto A; Sala A; Malucchi S; Marnetto F; Caldano M; Di Sapio A; Capobianco M; Gilli F;

Neutralizing antibodies reduce the efficacy of betaIFN during treatment of multiple sclerosis. in Neurology / Neurology. 2004 Jun 8;62(11):2031-7. doi: 10.1212/01.wnl.0000129265.73259.9e.
2004
AOU San Luigi di Orbassano

Malucchi S; Sala A; Gilli F; Bottero R; Di Sapio A; Capobianco M; Bertolotto A;

Immunogenicity of interferon beta: differences among products. in Journal of neurology / J Neurol. 2004 Jun;251 Suppl 2:II15-II24. doi: 10.1007/s00415-004-1204-7.
2004
AOU San Luigi di Orbassano

Bertolotto A; Deisenhammer F; Gallo P; Sölberg Sørensen P;

Neutralizing antibodies to interferon beta: implications for the management of multiple sclerosis. in Current opinion in neurology / Curr Opin Neurol. 2004 Jun;17(3):241-6. doi: 10.1097/00019052-200406000-00002.
2004
AOU San Luigi di Orbassano

Bertolotto A;

Comparison of three PCR assays for the evaluation of interferon-beta biological activity in patients with multiple sclerosis. in Molecular diagnosis : a journal devoted to the understanding of human disease through the clinical application of molecular biology / Mol Diagn. 2004;8(3):185-94. doi: 10.1007/BF03260063.
2004
AOU San Luigi di Orbassano

Gilli F; Marnetto F; Stefanuto G; Rinaldi V; Farinazzo F; Malucchi S; Capobianco M; Caldano M; Sala A; Bertolotto A;

Neuromyelitis optica: importance of cerebrospinal fluid examination during relapse. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2003 Oct;24(3):130-3. doi: 10.1007/s10072-003-0098-y.
2003
AOU San Luigi di Orbassano

Milano E; Di Sapio A; Malucchi S; Capobianco M; Bottero R; Sala A; Gilli F; Bertolotto A;

Persistent neutralizing antibodies abolish the interferon beta bioavailability in MS patients. in Neurology / Neurology. 2003 Feb 25;60(4):634-9. doi: 10.1212/01.wnl.0000046662.03894.c5.
2003
AOU San Luigi di Orbassano

Bertolotto A; Gilli F; Sala A; Capobianco M; Malucchi S; Milano E; Melis F; Marnetto F; Lindberg RL; Bottero R; Di Sapio A; Giordana MT;

Differential effects of three interferon betas on neutralising antibodies in patients with multiple sclerosis: a follow up study in an independent laboratory. in Journal of neurology, neurosurgery, and psychiatry / J Neurol Neurosurg Psychiatry. 2002 Aug;73(2):148-53. doi: 10.1136/jnnp.73.2.148.
2002
AOU San Luigi di Orbassano

Bertolotto A; Malucchi S; Sala A; Orefice G; Carrieri PB; Capobianco M; Milano E; Melis F; Giordana MT;

Evaluation of IFNalpha bioavailability by MxA mRNA in HCV patients. in Journal of immunological methods / J Immunol Methods. 2002 Apr 1;262(1-2):187-90. doi: 10.1016/s0022-1759(02)00008-x.
2002
AOU San Luigi di Orbassano

Gilli F; Sala A; Bancone C; Salacone P; Gallo M; Gaia E; Bertolotto A;

Evaluation of bioavailability of three types of IFNbeta in multiple sclerosis patients by a new quantitative-competitive-PCR method for MxA quantification. in Journal of immunological methods / J Immunol Methods. 2001 Oct 1;256(1-2):141-52. doi: 10.1016/s0022-1759(01)00434-3.
2001
AOU San Luigi di Orbassano

Bertolotto A; Gilli F; Sala A; Audano L; Castello A; Magliola U; Melis F; Giordana MT;

Interferon beta neutralizing antibodies in multiple sclerosis: neutralizing activity and cross-reactivity with three different preparations. in Immunopharmacology / Immunopharmacology. 2000 Jul 20;48(2):95-100. doi: 10.1016/s0162-3109(00)00182-x.
2000
AOU San Luigi di Orbassano

Bertolotto A; Malucchi S; Milano E; Castello A; Capobianco M; Mutani R;

Transforming growth factor beta1 (TGFbeta1) mRNA level correlates with magnetic resonance imaging disease activity in multiple sclerosis patients. in Neuroscience letters / Neurosci Lett. 1999 Mar 19;263(1):21-4. doi: 10.1016/s0304-3940(99)00102-0.
1999
AOU San Luigi di Orbassano

Bertolotto A; Capobianco M; Malucchi S; Manzardo E; Audano L; Bergui M; Bradac GB; Mutani R;

Quantitative PCR reveals increased levels of tumor necrosis factor-alpha mRNA in peripheral blood mononuclear cells of multiple sclerosis patients during relapses. in Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research / J Interferon Cytokine Res. 1999 Jun;19(6):575-81. doi: 10.1089/107999099313703.
1999
AOU San Luigi di Orbassano

Bertolotto A; Malucchi S; Capobianco M; Manzardo E; Guastamacchia G; Milano E; Audano L; Mutani R;

5D4 keratan sulfate epitope identifies a subset of ramified microglia in normal central nervous system parenchyma. in Journal of neuroimmunology / J Neuroimmunol. 1998 May 1;85(1):69-77. doi: 10.1016/s0165-5728(97)00251-8.
1998
AOU San Luigi di Orbassano

Bertolotto A; Agresti C; Castello A; Manzardo E; Riccio A;

Keratan sulphate is a marker of differentiation of ramified microglia. in Brain research. Developmental brain research / Brain Res Dev Brain Res. 1995 May 26;86(1-2):233-41. doi: 10.1016/0165-3806(95)00030-h.
1995
AOU San Luigi di Orbassano

Bertolotto A; Manzardo E; Iudicello M; Guglielmone R; Riccio A;

1995
AOU San Luigi di Orbassano

Bertolotto A; Manzardo E; Iudicello M; Lovisetto C; Riccio A;